Competition had a win today
Clarity Pharmaceuticals (ASX: CU6) (“Clarity”), a clinical-stage radiopharmaceutical company with a mission to
develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to
announce that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for 64Cu-SARbisPSMA for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive
prostate cancer lesions with suspected metastasis who are candidates for initial definitive therapy
I don't hold TLX yet Its overpriced IMHO ATM just researching to see if its hype or real deal.
Understanding Telix, page-1335
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$21.45 |
Change
0.520(2.48%) |
Mkt cap ! $7.178B | |||
| Open | High | Low | Value | Volume |
| $20.83 | $21.50 | $20.80 | $17.54M | 824.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2037 | $21.45 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $21.50 | 12320 | 5 |
View Market Depth
| Last trade - 16.10pm 01/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |